C4 Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 16,322 | 0.0238% |
Individual Insiders | 1,834,744 | 2.67% |
Hedge Funds | 3,800,000 | 5.54% |
VC/PE Firms | 4,878,000 | 7.11% |
General Public | 4,969,330 | 7.24% |
Public Companies | 5,567,928 | 8.12% |
Institutions | 47,534,345 | 69.3% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 39.9%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
7,153,280 | US$49.4m | 4,500% | no data | |||
5,567,928 | US$38.5m | 0% | no data | |||
5,516,718 | US$38.1m | -22.7% | 0.14% | |||
4,878,000 | US$33.7m | 0% | 0.44% | |||
3,800,000 | US$26.3m | 0% | 1.84% | |||
3,134,396 | US$21.7m | 208% | 4.45% | |||
2,676,696 | US$18.5m | 17.6% | 0.04% | |||
2,558,480 | US$17.7m | 17% | no data | |||
2,555,996 | US$17.7m | 39.2% | 1.89% | |||
2,370,504 | US$16.4m | 0% | 60.23% | |||
2,137,381 | US$14.8m | -10.1% | 0.17% | |||
1,999,401 | US$13.8m | 3.87% | no data | |||
1,803,433 | US$12.5m | -13.9% | no data | |||
1,704,269 | US$11.8m | 0% | 0.03% | |||
1,675,097 | US$11.6m | 3,610% | 0.01% | |||
1,642,210 | US$11.3m | 0% | 1.04% | |||
1,276,574 | US$8.8m | 0% | 0.77% | |||
1,123,061 | US$7.8m | 0% | 0.02% | |||
1,093,640 | US$7.6m | 576% | 0.01% | |||
792,682 | US$5.5m | 0.39% | no data | |||
732,145 | US$5.1m | -37.3% | no data | |||
692,082 | US$4.8m | 1,130% | no data | |||
489,542 | US$3.4m | 0% | no data | |||
482,288 | US$3.3m | 5.8% | no data | |||
424,700 | US$2.9m | 18.6% | no data |